These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14500671)

  • 1. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.
    Yang OO; Sarkis PT; Trocha A; Kalams SA; Johnson RP; Walker BD
    J Immunol; 2003 Oct; 171(7):3718-24. PubMed ID: 14500671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
    J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.
    Bennett MS; Ng HL; Dagarag M; Ali A; Yang OO
    J Virol; 2007 May; 81(10):4973-80. PubMed ID: 17329324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
    Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
    J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.
    Adnan S; Balamurugan A; Trocha A; Bennett MS; Ng HL; Ali A; Brander C; Yang OO
    Blood; 2006 Nov; 108(10):3414-9. PubMed ID: 16882705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs.
    Ueno T; Idegami Y; Motozono C; Oka S; Takiguchi M
    J Immunol; 2007 May; 178(9):5513-23. PubMed ID: 17442933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
    Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
    J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
    Motozono C; Yanaka S; Tsumoto K; Takiguchi M; Ueno T
    J Immunol; 2009 May; 182(9):5528-36. PubMed ID: 19380801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
    Ali A; Ng HL; Dagarag MD; Yang OO
    Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.
    Woodberry T; Gardner J; Mateo L; Eisen D; Medveczky J; Ramshaw IA; Thomson SA; Ffrench RA; Elliott SL; Firat H; Lemonnier FA; Suhrbier A
    J Virol; 1999 Jul; 73(7):5320-5. PubMed ID: 10364278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
    J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.